(1)The pharmacologicalactions and therapeutic uses of cholinoceptor-bloking drugs (2)The majoradverse reactions of cholinoceptor-bloking drugs 3.Course Contents 3.1 Classification and structure of cholinoceptor-bloking drugs. 3.2 The structure and pharmacokinetics of muscarinic receptor-blocking drugs. 3.3 The mechanism ofaction of muscarinic receptor-blocking drugs 3.4 Pharmacologicaleffects of muscarinic receptor-blocking drugs. 3.5 The therapeutic applications of muscarinic receptor-blocking drugs. 3.6 Adverse effectsofmuscarinic receptor-blocking drugs. 3.7 Ganglion-blocking drugs. 4.Teaching Methods By using multimedia teaching method,off-line,on-line method,student-centered method and otherdiversified teaching methods,we inspire students to"leam with questions"and cultivate students'critical thinking ability. 5.Teaching Evaluation Questions: 1.To describe the muscarinic receptor subgroups and their antagonists. 2.To describe the pharmacologicaleffectsofatropine. 3.To describe the clinical uses of muscarinic blocking drugs. Chapter9 Adrenoceptor Agonists Sympathomimetic Drugs 1.Teaching Objectives 1.1 To learn the distribution of those adrenoceptorsubtypes.(1) The pharmacological actions and therapeutic uses of cholinoceptor-bloking drugs (2) The major adverse reactions of cholinoceptor-bloking drugs 3. Course Contents 3.1 Classification and structure of cholinoceptor-bloking drugs. 3.2 The structure and pharmacokinetics of muscarinic receptor-blocking drugs. 3.3 The mechanism of action of muscarinic receptor-blocking drugs. 3.4 Pharmacological effects of muscarinic receptor-blocking drugs. 3.5 The therapeutic applications of muscarinic receptor-blocking drugs. 3.6 Adverse effects of muscarinic receptor-blocking drugs. 3.7 Ganglion-blocking drugs. 4.Teaching Methods By using multimedia teaching method, off-line, on-line method, student-centered method and other diversified teaching methods, we inspire students to “learn with questions” and cultivate students’ critical thinking ability. 5.Teaching Evaluation Questions： 1. To describe the muscarinic receptor subgroups and their a ntagonists. 2. To describe the pharmacological effects of atropine. 3. To describe the clinical uses of muscarinic blocking drugs. Chapter9 Adrenoceptor Agonists & Sympathomimetic Drugs 1.Teaching Objectives 1.1 To learn the distribution of those adrenoceptor subtypes